Predictors for Post-treatment Biopsy Outcomes after Prostate Stereotactic Body Radiotherapy.

To investigate predictors associated with post-treatment biopsy outcomes after stereotactic body radiotherapy (SBRT) for localized prostate cancer.

257 patients treated with prostate SBRT to dose levels of 32.